RUFY4

gene
On this page

Also known as FLJ46536ZFYVE31

Summary

RUFY4 (RUN and FYVE domain containing 4, HGNC:24804) is a protein-coding gene on chromosome 2q35, encoding RUN and FYVE domain-containing protein 4 (Q6ZNE9). ARL8 effector that promotes the coupling of endolysosomes to dynein-dynactin for retrograde transport along microtubules.

Enables phosphatidylinositol-3-phosphate binding activity. Involved in autophagosome assembly; cellular response to interleukin-4; and positive regulation of macroautophagy. Located in autophagosome.

Source: NCBI Gene 285180 — RefSeq curated summary.

At a glance

  • GWAS associations: 3
  • Clinical variants (ClinVar): 116 total
  • MANE Select transcript: NM_198483

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:24804
Approved symbolRUFY4
NameRUN and FYVE domain containing 4
Location2q35
Locus typegene with protein product
StatusApproved
AliasesFLJ46536, ZFYVE31
Ensembl geneENSG00000188282
Ensembl biotypeprotein_coding
OMIM620994
Entrez285180

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 6 protein_coding_CDS_not_defined, 3 protein_coding, 1 nonsense_mediated_decay, 1 retained_intron

ENST00000344321, ENST00000374155, ENST00000457754, ENST00000463618, ENST00000463872, ENST00000465568, ENST00000472496, ENST00000480164, ENST00000495721, ENST00000497857, ENST00000697321

RefSeq mRNA: 1 — MANE Select: NM_198483 NM_198483

Canonical transcript exons

ENST00000697321 — 13 exons

ExonStartEnd
ENSE00001386201218070753218070859
ENSE00001462614218073816218073885
ENSE00001462616218072779218072885
ENSE00001702335218089952218090584
ENSE00001709916218069253218069348
ENSE00002449418218069481218069558
ENSE00003484646218076427218076533
ENSE00003488695218089252218089362
ENSE00003498596218072374218072499
ENSE00003584110218075093218075740
ENSE00003615421218073243218073386
ENSE00003617790218070500218070651
ENSE00003683022218083110218083256

Expression profiles

Bgee: expression breadth ubiquitous, 120 present calls, max score 78.06.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0149 / max 4.7238, expressed in 6 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
252720.01496

Top tissues by expression

133 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047378.06gold quality
granulocyteCL:000009477.69gold quality
monocyteCL:000057675.87gold quality
leukocyteCL:000073875.17gold quality
spleenUBERON:000210666.62gold quality
lymph nodeUBERON:000002965.90gold quality
bloodUBERON:000017865.56gold quality
bone marrowUBERON:000237165.01gold quality
bone marrow cellCL:000209264.39gold quality
vermiform appendixUBERON:000115464.17gold quality
gall bladderUBERON:000211062.05gold quality
olfactory segment of nasal mucosaUBERON:000538661.63gold quality
duodenumUBERON:000211461.48gold quality
tonsilUBERON:000237259.73gold quality
rectumUBERON:000105258.72gold quality
lower esophagus mucosaUBERON:003583458.34gold quality
Ammon’s hornUBERON:000195457.16gold quality
prostate glandUBERON:000236756.79gold quality
small intestineUBERON:000210855.74gold quality
small intestine Peyer’s patchUBERON:000345455.36gold quality
right uterine tubeUBERON:000130254.66gold quality
urinary bladderUBERON:000125554.33gold quality
amygdalaUBERON:000187653.66gold quality
temporal lobeUBERON:000187153.60gold quality
esophagus mucosaUBERON:000246952.88gold quality
right adrenal gland cortexUBERON:003582752.14gold quality
right coronary arteryUBERON:000162551.92gold quality
left adrenal glandUBERON:000123451.60gold quality
mucosa of transverse colonUBERON:000499151.44gold quality
substantia nigraUBERON:000203851.34gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no3.08

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

34 targeting RUFY4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4481100.0066.421669
HSA-MIR-6758-5P100.0066.211470
HSA-MIR-6856-5P100.0065.471298
HSA-MIR-4745-5P99.9865.951028
HSA-MIR-480399.9871.993117
HSA-MIR-314399.9371.963104
HSA-MIR-6721-5P99.9368.922981
HSA-MIR-95-5P99.8972.173973
HSA-MIR-4731-5P99.8967.232537
HSA-MIR-449299.8768.253611
HSA-MIR-76599.8468.242442
HSA-MIR-467999.7669.191229
HSA-MIR-431999.7669.832586
HSA-MIR-11181-3P99.7566.382205
HSA-MIR-130399.6569.771662
HSA-MIR-76299.5866.611994
HSA-MIR-6733-3P99.5467.801281
HSA-MIR-444199.4966.563216
HSA-MIR-449899.4767.422360
HSA-MIR-508-5P99.4164.251248
HSA-MIR-3692-5P99.2967.041421
HSA-MIR-5001-5P99.0566.761972
HSA-MIR-6829-5P98.8665.121480
HSA-MIR-4536-5P98.4764.39657
HSA-MIR-6765-3P97.8364.591165
HSA-MIR-519296.8963.35879
HSA-MIR-3126-5P96.8765.83912
HSA-MIR-6875-5P96.8765.49958
HSA-MIR-7847-3P96.6364.58952
HSA-MIR-451595.7065.73716

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusRufy4ENSMUSG00000061815
rattus_norvegicusRufy4ENSRNOG00000032991

Paralogs (1): FYCO1 (ENSG00000163820)

Protein

Protein identifiers

RUN and FYVE domain-containing protein 4Q6ZNE9 (reviewed: Q6ZNE9)

All UniProt accessions (2): C9J235, Q6ZNE9

UniProt curated annotations — full annotation on UniProt →

Function. ARL8 effector that promotes the coupling of endolysosomes to dynein-dynactin for retrograde transport along microtubules. Acts by binding both GTP-bound ARL8 and dynein-dynactin. In nonneuronal cells, promotes concentration of endolysosomes in the juxtanuclear area. In hippocampal neurons, drives retrograde transport of endolysosomes from the axon to the soma. Positive regulator of macroautophagy in dendritic cells. Increases autophagic flux, probably by stimulating both autophagosome formation and facilitating tethering with lysosomes. Binds to phosphatidylinositol 3-phosphate (PtdIns3P) through its FYVE-type zinc finger. Positive regulator of osteosclast bone-resorbing activity, possibly by promoting late endosome-lysosome fusion by acting as an adapter protein between RAB7A on late endosomes and LAMP2 on primary lysosomes.

Subunit / interactions. Forms homodimers (via coiled coil domain). Interacts with RAB7A. Forms a ternary complex with RAB7A and LAMP2; the interaction with RAB7A is mediated by RUFY4 (via RUN and coiled coil domains). Interacts with GTP-, but not GDP-bound ARL8A and ARL8B. Interacts with dynactin/DCTN1 and the dynein intermediate chain DYNC1I1/2.

Subcellular location. Cytoplasmic vesicle. Autophagosome. Lysosome.

Domain organisation. The RUN domain and the FYVE-type zinc finger are essential for its function in the positive regulation of macroautophagy.

Induction. Up-regulated by IL4/interleukin-4 in monocyte-derived dendritic cells.

Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.

Isoforms (2)

UniProt IDNamesCanonical?
Q6ZNE9-21yes
Q6ZNE9-32

RefSeq proteins (1): NP_940885* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR004012Run_domDomain
IPR011011Znf_FYVE_PHDHomologous_superfamily
IPR013083Znf_RING/FYVE/PHDHomologous_superfamily
IPR017455Znf_FYVE-relDomain
IPR037213Run_dom_sfHomologous_superfamily
IPR042939RUFY4Family
IPR059036RUFY4_domDomain

Pfam: PF02759, PF25366

UniProt features (16 total): binding site 8, splice variant 2, chain 1, domain 1, zinc finger region 1, region of interest 1, coiled-coil region 1, compositionally biased region 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6ZNE9-F168.070.38

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (8): 545; 548; 559; 562; 521; 524; 537; 540

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 105 (showing top): GOBP_REGULATION_OF_AUTOPHAGY, GOBP_AXO_DENDRITIC_TRANSPORT, GOBP_LYSOSOMAL_TRANSPORT, GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS, GOBP_VACUOLE_ORGANIZATION, GOBP_RESPONSE_TO_INTERLEUKIN_4, GOBP_RESPONSE_TO_PEPTIDE, GOBP_VESICLE_ORGANIZATION, GOBP_ENDOSOME_TO_LYSOSOME_TRANSPORT, GOBP_MEMBRANE_FUSION, GOBP_REGULATION_OF_EXOCYTOSIS, GOBP_VACUOLAR_TRANSPORT, GOBP_VESICLE_MEDIATED_TRANSPORT, CAGCTG_AP4_Q5, GOBP_MACROAUTOPHAGY

GO Biological Process (8): autophagosome assembly (GO:0000045), positive regulation of macroautophagy (GO:0016239), positive regulation of bone resorption (GO:0045780), positive regulation of exocytosis (GO:0045921), multivesicular body-lysosome fusion (GO:0061763), cellular response to interleukin-4 (GO:0071353), positive regulation of retrograde axon cargo transport (GO:2001019), autophagy (GO:0006914)

GO Molecular Function (5): zinc ion binding (GO:0008270), phosphatidylinositol-3-phosphate binding (GO:0032266), dynactin binding (GO:0034452), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (4): autophagosome (GO:0005776), endolysosome (GO:0036019), lysosome (GO:0005764), cytoplasmic vesicle (GO:0031410)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
Atg12 activating enzyme activity1
protein-phosphatidylethanolamide deconjugating activity1
Atg12 conjugating enzyme activity1
Atg12 ligase activity1
organelle assembly1
Atg1/ULK1 kinase complex assembly1
autophagosome organization1
positive regulation of autophagy1
macroautophagy1
regulation of macroautophagy1
regulation of bone resorption1
bone resorption1
positive regulation of multicellular organismal process1
exocytosis1
regulation of exocytosis1
positive regulation of secretion by cell1
vesicle fusion1
endosome to lysosome transport via multivesicular body sorting pathway1
lysosomal membrane organization1
response to interleukin-41
cellular response to cytokine stimulus1
retrograde axonal transport1
positive regulation of intracellular transport1
regulation of retrograde axon cargo transport1
catabolic process1
transmembrane transport1
process utilizing autophagic mechanism1
transition metal ion binding1
phosphatidylinositol phosphate binding1
cytoskeletal protein binding1
binding1
cation binding1
vacuole1
lysosome1
endosome1
lytic vacuole1
cytoplasm1
intracellular vesicle1

Protein interactions and networks

STRING

486 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RUFY4RUFY2Q8WXA3683
RUFY4ARL5BQ96KC2552
RUFY4ZNF142P52746532
RUFY4TMBIM1Q969X1464
RUFY4PLEKHM1Q9Y4G2444
RUFY4STK36Q9NRP7432
RUFY4TTLL7Q6ZT98419
RUFY4RUNDC3AQ59EK9419
RUFY4KRTAP10-8P60410418
RUFY4TMEM44Q2T9K0402
RUFY4SNRNP48Q6IEG0397
RUFY4RNF175Q8N4F7396
RUFY4KRTAP4-1Q9BYQ7392
RUFY4RAB33AQ14088380
RUFY4NAA30Q147X3368

IntAct

44 interactions, top by confidence:

ABTypeScore
NDC80RUFY4psi-mi:“MI:0915”(physical association)0.830
RUFY4NDC80psi-mi:“MI:0915”(physical association)0.830
RUFY4NDC80psi-mi:“MI:0914”(association)0.830
RUFY4LNX1psi-mi:“MI:0915”(physical association)0.720
RUFY4MAP1LC3Cpsi-mi:“MI:0915”(physical association)0.560
CDKN2DRUFY4psi-mi:“MI:0915”(physical association)0.560
RUFY4DMWDpsi-mi:“MI:0915”(physical association)0.560
RUFY4GFAPpsi-mi:“MI:0915”(physical association)0.560
LMNARUFY4psi-mi:“MI:0915”(physical association)0.560
RUFY4NF2psi-mi:“MI:0915”(physical association)0.560
TSC1RUFY4psi-mi:“MI:0915”(physical association)0.560
RUFY4SPRED1psi-mi:“MI:0915”(physical association)0.560
HTTRUFY4psi-mi:“MI:0915”(physical association)0.560

BioGRID (21): RUFY4 (Two-hybrid), RUFY4 (Two-hybrid), TRAPPC9 (Affinity Capture-MS), TRAPPC9 (Affinity Capture-MS), RUFY4 (Two-hybrid), RUFY4 (Two-hybrid), RUFY4 (Two-hybrid), RUFY4 (Two-hybrid), MAP1LC3C (Two-hybrid), TRAPPC9 (Affinity Capture-MS), TRAPPC10 (Affinity Capture-MS), TRAPPC6B (Affinity Capture-MS), TRAPPC5 (Affinity Capture-MS), TRAPPC2 (Affinity Capture-MS), NDC80 (Affinity Capture-MS)

ESM2 similar proteins: A1L443, A2IDD5, A4IFI1, A6NJZ7, A6NNL0, A6NNM3, A8MT33, B1AL46, D3Z5T1, O95153, Q2M3G4, Q2T9R2, Q3TVI4, Q3TYX8, Q49AM3, Q4KLY2, Q569K6, Q5JTD0, Q5JXC2, Q5SSQ6, Q5SW24, Q5VT03, Q5VZR2, Q6ZNE9, Q7TN08, Q7TNF8, Q7Z591, Q80VJ8, Q810H6, Q811T9, Q86SX3, Q8C963, Q8CB62, Q8CII8, Q8IVF1, Q8IXR5, Q8N0S2, Q8N137, Q8N205, Q8N6L0

Diamond homologs: Q3TYX8, Q6NXD8, Q6ZNE9, Q6ZUT9, Q8VDC1, Q9BQS8, A2RSQ0, A7YDW0, O08576, Q08DX0, Q08E29, Q0V9V7, Q17QK1, Q3B7K9, Q4R7B9, Q59EK9, Q5FVJ0, Q5NVC2, Q5R4V2, Q5R565, Q5R5R4, Q5U3W3, Q6PDC0, Q7L099, Q8BIJ7, Q8R4C2, Q8TEQ0, Q8WXA3, Q96NL0, Q96T51, Q9D394, A8QCE4, A8XJZ8, B0G126, B4JHI7, D3ZVP7, O14964, O17907, O59722, O76054

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

116 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance95
Likely benign15
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1898 predictions. Top by Δscore:

VariantEffectΔscore
2:218070648:AGAGG:Adonor_loss1.0000
2:218070649:GAG:Gdonor_gain1.0000
2:218070649:GAGGT:Gdonor_loss1.0000
2:218070652:GTG:Gdonor_loss1.0000
2:218070653:T:Gdonor_loss1.0000
2:218072365:T:Aacceptor_gain1.0000
2:218072370:CTAGT:Cacceptor_loss1.0000
2:218072372:A:AGacceptor_gain1.0000
2:218072372:AGTTT:Aacceptor_gain1.0000
2:218072373:G:GAacceptor_gain1.0000
2:218072373:GT:Gacceptor_gain1.0000
2:218072373:GTT:Gacceptor_gain1.0000
2:218072373:GTTT:Gacceptor_gain1.0000
2:218072373:GTTTG:Gacceptor_gain1.0000
2:218073385:GA:Gdonor_gain1.0000
2:218073387:G:GGdonor_gain1.0000
2:218083257:G:GGdonor_gain1.0000
2:218070652:G:GGdonor_gain0.9900
2:218071830:G:GTdonor_gain0.9900
2:218072361:ATTTT:Aacceptor_gain0.9900
2:218072366:G:Aacceptor_gain0.9900
2:218072499:GGTA:Gdonor_loss0.9900
2:218072777:A:AGacceptor_gain0.9900
2:218072778:G:GGacceptor_gain0.9900
2:218073239:ACAG:Aacceptor_gain0.9900
2:218073391:G:GGdonor_gain0.9900
2:218073946:T:Gdonor_gain0.9900
2:218077583:T:TAacceptor_gain0.9900
2:218083262:G:GTdonor_gain0.9900
2:218070650:AG:Adonor_gain0.9800

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000026092 (2:218063616 A>T), RS1000085395 (2:218072321 C>A,T), RS1000120793 (2:218077085 G>A,T), RS1000165553 (2:218047208 C>A), RS1000207270 (2:218088066 T>C), RS1000244996 (2:218067284 C>A,T), RS1000297101 (2:218056342 T>C), RS1000323641 (2:218034501 G>A,T), RS1000372454 (2:218053306 T>A), RS1000447057 (2:218059590 A>G,T), RS1000487610 (2:218077998 G>A), RS1000502820 (2:218050193 G>A), RS1000503540 (2:218048331 A>G), RS1000603992 (2:218055095 A>G), RS1000611208 (2:218081898 CAT>C)

Disease associations

OMIM: gene MIM:620994 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

3 associations (top):

StudyTraitp-value
GCST004131_76Inflammatory bowel disease2.000000e-07
GCST004618_56White blood cell count (basophil)8.000000e-10
GCST008163_577Height3.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0005090basophil count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

6 total (human), top 6 by PubMed support.

ChemicalActions (top 5)PubMed papers
ethyl-p-hydroxybenzoatedecreases expression1
bisphenol Sdecreases methylation1
Benzo(a)pyreneincreases methylation1
Cadmiumdecreases expression1
Valproic Acidincreases methylation1
Aflatoxin B1decreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.